The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
- PMID: 18302232
- PMCID: PMC2544629
- DOI: 10.1002/jmri.21049
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
Abstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multisite observational study of healthy elders, mild cognitive impairment (MCI), and Alzheimer's disease. Magnetic resonance imaging (MRI), (18F)-fluorodeoxyglucose positron emission tomography (FDG PET), urine serum, and cerebrospinal fluid (CSF) biomarkers, as well as clinical/psychometric assessments are acquired at multiple time points. All data will be cross-linked and made available to the general scientific community. The purpose of this report is to describe the MRI methods employed in ADNI. The ADNI MRI core established specifications that guided protocol development. A major effort was devoted to evaluating 3D T(1)-weighted sequences for morphometric analyses. Several options for this sequence were optimized for the relevant manufacturer platforms and then compared in a reduced-scale clinical trial. The protocol selected for the ADNI study includes: back-to-back 3D magnetization prepared rapid gradient echo (MP-RAGE) scans; B(1)-calibration scans when applicable; and an axial proton density-T(2) dual contrast (i.e., echo) fast spin echo/turbo spin echo (FSE/TSE) for pathology detection. ADNI MRI methods seek to maximize scientific utility while minimizing the burden placed on participants. The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom-based monitoring of all scanners could be used as a model for other multisite trials.
(c) 2008 Wiley-Liss, Inc.
Figures






Similar articles
-
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001. Alzheimers Dement. 2015. PMID: 26073027 Free PMC article. Review.
-
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.Alzheimers Dement. 2010 May;6(3):212-20. doi: 10.1016/j.jalz.2010.03.004. Alzheimers Dement. 2010. PMID: 20451869 Free PMC article. Review.
-
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7. Alzheimers Dement. 2013. PMID: 23932184 Free PMC article. Review.
-
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Epub 2011 Nov 2. Alzheimers Dement. 2012. PMID: 22047634 Free PMC article. Review.
-
Whole brain quantitative T2 MRI across multiple scanners with dual echo FSE: applications to AD, MCI, and normal aging.Neuroimage. 2010 Aug 15;52(2):508-14. doi: 10.1016/j.neuroimage.2010.04.255. Epub 2010 May 2. Neuroimage. 2010. PMID: 20441797 Free PMC article.
Cited by
-
Comprehensive Visual Rating Scale on Magnetic Resonance Imaging: Application to Prodromal Alzheimer Disease.Ann Geriatr Med Res. 2021 Mar;25(1):39-44. doi: 10.4235/agmr.21.0010. Epub 2021 Mar 15. Ann Geriatr Med Res. 2021. PMID: 33715339 Free PMC article.
-
Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.Alzheimers Dement. 2015 Jul;11(7):740-56. doi: 10.1016/j.jalz.2015.05.002. Alzheimers Dement. 2015. PMID: 26194310 Free PMC article.
-
Cerebral Microbleeds: Relationship to Antithrombotic Medications.Stroke. 2021 Jul;52(7):2347-2355. doi: 10.1161/STROKEAHA.120.031515. Epub 2021 May 10. Stroke. 2021. PMID: 33966498 Free PMC article.
-
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):716-24. doi: 10.1007/s00259-014-2975-4. Epub 2015 Jan 29. Eur J Nucl Med Mol Imaging. 2015. PMID: 25631614 Free PMC article.
-
Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity.J Neurosci. 2015 Jan 28;35(4):1781-91. doi: 10.1523/JNEUROSCI.2998-14.2015. J Neurosci. 2015. PMID: 25632151 Free PMC article.
References
-
- Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain. 1996;119:2001–2007. - PubMed
-
- Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet. 2001;358:201–205. - PubMed
-
- Xu Y, Jack C, Jr, O'Brien PC, et al. Usefulness of MRI measures of entorhinal cortex vs hippocampus in AD. Neurology. 2000;54:1760–1767. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical